XML 36 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Loss and Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues:    
Product and service revenues $ 69,731 $ 102,368
Cost of product and service revenues 91,713 124,199
Gross margin (21,982) (21,831)
Operating expenses:    
Research and product development 94,494 98,306
General and administrative 23,516 23,874
Sales and marketing 13,502 15,110
Other expense 29,806 3,783
Total operating expenses 161,318 141,073
Results from operating activities (183,300) (162,904)
Finance income and other 18,933 31,055
Finance expense (2,146) (1,105)
Net finance income 16,787 29,950
Equity in loss of investment in joint venture and associates (4,941) (10,131)
Impairment charges on property, plant and equipment (111,020) (967)
Impairment charges on intangible assets (658) 0
Impairment charges on goodwill (40,277) 0
Loss before income taxes (323,409) (144,052)
Income tax expense (121) (158)
Net loss from continued operations (323,530) (144,210)
Net loss from discontinued operations (715) (33,506)
Net loss (324,245) (177,716)
Items that will not be reclassified to profit or loss:    
Actuarial gain on defined benefit plans 913 970
Items that may be reclassified subsequently to profit or loss:    
Foreign currency translation differences (1,803) (1,472)
Other comprehensive loss, net of tax (890) (502)
Total comprehensive loss $ (325,135) $ (178,218)
Basic and diluted loss per share    
Continued operations, basic (in USD per share) $ (1.08) $ (0.48)
Continued operations, diluted (in USD per share) (1.08) (0.48)
Discontinued operations, basic (in USD per share) 0 (0.11)
Discontinued operations, diluted (in USD per share) 0 (0.11)
Loss per share for the period, basic (in USD per share) (1.08) (0.59)
Loss per share for the period, diluted (in USD per share) $ (1.08) $ (0.59)
Weighted average number of common shares outstanding (shares) 299,310,384 298,661,041